Treatment of anxiety disorders in the Finnish general population

被引:18
|
作者
Sihvo, Sinikka
Hamalainen, Juha
Kiviruusu, Olli
Pirkola, Sami
Isometsa, Erkki
机构
[1] STAKES, Natl Res & Dev Ctr Welf & Hlth, Helsinki 00531, Finland
[2] Eastern Hlth Ctr, Helsinki City Dept, Dept Psychiat, Helsinki, Finland
[3] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland
[4] Univ Helsinki, Dept Psychiat, Helsinki, Finland
基金
芬兰科学院;
关键词
anxiety disorders; psychotropics; antidepressants; anxiolytics; population-based survey;
D O I
10.1016/j.jad.2006.05.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Treatments for anxiety disorders in the general population are not widely investigated. We determined the proportion, type and determinants of treatment in the Finnish general population. Methods: Within the Health 2000 Study, a representative sample (n = 6005) of adults (age > 30 years) were interviewed in 20002001 with the Composite International Diagnostic Interview (M-CIDI) to assess the presence of DSM-IV mental disorders during the preceding 12 months. Logistic regression models were used to examine factors influencing the type of treatment (phartnacotherapy and/or psychological treatment) and also the types of pharmacotherapy (antidepressants, anxiolytics, or sedatives and hypnotics) used for anxiety disorders. Results: For individuals with an anxiety disorder, 40% (95/229) currently used psychotropic medication, 23% (55/229) used antidepressants, 19% (44/229) anxiolytics and 17% (41/229) sedatives or hypnotics. Of those using health care services for mental health reasons (34%, 76/229), 80% (61/76) received pharmacotherapy. Only 45% (34/76) reported having psychological treatment, with few having more than 4 visits (27%, 20/76). Living in a semi-urban environment, retirement and high perceived disability increased the likelihood of pharmacotherapy-only treatment; higher education and comorbidity with mood disorders increased the likelihood of psychological treatment. General practitioners more often than psychiatrists provided pharmacotherapy treatment alone (67% vs. 34%, p < 0.05), particularly anxiolytics or sedatives. Limitations: Use of mental health services and psychological treatment were based on self-reports. No data on duration of pharmacotherapy was available. Conclusions: Anxiety disorders remain largely untreated in the general population. Among those seeking treatment, pharmacotherapy predominates, whereas even brief psychotherapies are rare. Contrary to clinical guidelines, anxiolytics and sedatives are commonly used instead of antidepressants. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 50 条
  • [1] Seasonality contributes to depressive, anxiety and alcohol use disorders in the Finnish general adult population
    Palmu, Raimo
    Koskinen, Seppo
    Partonen, Timo
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2022, 311 : 84 - 87
  • [2] The lifetime prevalence of psychotic disorders in the Finnish general population
    Ukkola, J
    Suvisaari, J
    Saami, S
    Kuoppasalmi, K
    Isometsä, E
    Pirkola, S
    Lönnqvist, J
    [J]. SCHIZOPHRENIA RESEARCH, 2006, 81 : 187 - 187
  • [3] Antidepressant treatment of depression in the Finnish general population
    Laukkala, T
    Isometsä, E
    Hämäläinen, J
    Heikkinen, M
    Lindeman, S
    Aro, H
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (12): : 2077 - 2079
  • [4] Evaluation and treatment of anxiety disorders in the general pediatric population: A clinician's guide
    Lyneham, HJ
    Rapee, RM
    [J]. CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2005, 14 (04) : 845 - +
  • [5] Recurrence of anxiety disorders and its predictors in the general population
    Scholten, Willemijn
    ten Have, Margreet
    van Geel, Carmen
    van Balkom, Anton
    de Graaf, Ron
    Batelaan, Neeltje
    [J]. PSYCHOLOGICAL MEDICINE, 2023, 53 (04) : 1334 - 1342
  • [6] TREATMENT OF MAJOR DEPRESSIVE DISORDER IN THE FINNISH GENERAL POPULATION
    Hamalainen, Juha
    Isometsa, Erkki
    Sihvo, Sinikka
    Kiviruusu, Olli
    Pirkola, Sami
    Lonnqvist, Jouko
    [J]. DEPRESSION AND ANXIETY, 2009, 26 (11) : 1049 - 1059
  • [7] Toxoplasma gondii infection and common mental disorders in the Finnish general population
    Suvisaari, Jaana
    Torniainen-Holm, Minna
    Lindgren, Maija
    Harkanen, Tommi
    Yolken, Robert H.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2017, 223 : 20 - 25
  • [8] Differentiating DSM-IV anxiety and depressive disorders in the general population: Comorbidity and treatment consequences
    Ohayon, MM
    Shapiro, CM
    Kennedy, SH
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2000, 45 (02): : 166 - 172
  • [9] Substance use disorders comorbid with mood and anxiety disorders in the Australian general population
    Prior, Katrina
    Mills, Katherine
    Ross, Joanne
    Teesson, Maree
    [J]. DRUG AND ALCOHOL REVIEW, 2017, 36 (03) : 317 - 324
  • [10] Identifying target groups for the prevention of anxiety disorders in the general population
    Batelaan, N. M.
    Smit, F.
    de Graaf, R.
    van Balkom, A. J. L. M.
    Vollebergh, W. A. M.
    Beekman, A. T. F.
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2010, 122 (01) : 56 - 65